>
Everything I Warned You About Just Happened... All in One Week
Your Grief, My Grief, Our Grief in the Loss of a Loved One
Vance: Federal Government Has Identified $230 Billion In Fraud Since March
Saudi Arabia's $5 Oil Detour Is Expensive... But Worth It
What could possibly go wrong? Scientists use AI to design new viruses
Dual-motor suitcase drive underpins 3,000-hp hypercar
DoorDash Wins Federal Approval To Fly Its Own Delivery Drones
Shade-Resistant Solar Cells Retain 97% Efficiency After 2,000 Hours of Testing
20 Ancient Engineering SECRETS
Stonehenge Was Reanalyzed by AI -- And the Findings Are Hard to Explain
After Years Of Delays, Aptera Is Finally Preparing To Build Customer Cars
'When you kill it, it doesn't die': the jellyfish that has cracked the secret of immorta
Archer Aviation debuts Halo autonomous VTOL, Thunder's commercial twin
US Telecoms Slide On Starlink Mobile Threat; Bernstein Sees It As A "Jab, But No Knockout Yet**

Help may be on the way, however, as doctors have had success using a combination of an arthritis drug and ultraviolet light.
In previous studies, Dr. Brett King (of Yale University) and Dr. John Harris (from the University of Massachusetts-Worcester) had determined two things: the drug tofacitinib stops the immune system from attacking the skin cells that manufacture melanin pigment, and narrow-band UVB light helps restore skin color by stimulating pigment-making cells.
King recently had two patients with severe vitiligo, who hadn't responded to traditional treatments. After trying them on the tofacitinib/UVB combo for a few months, though, they both experienced near-total restoration of skin color in the affected areas.
While more research is still needed, King states that "These findings will define treatment of vitiligo in the future."